XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current Assets    
Cash and cash equivalents $ 7,528,000 $ 11,609,000
Tax credit receivable 1,721,000 3,228,000
Prepaid expenses and other current assets 654,000 1,444,000
Total Current Assets 9,903,000 16,281,000
Non-Current Assets    
Property and equipment, net 249,000 270,000
Restricted cash 46,000 96,000
Right of use asset 942,000 1,272,000
In-process research and development 19,614,000 17,358,000
Deposits and other assets 82,000 75,000
Total Assets 30,836,000 35,352,000
Current Liabilities:    
Accounts payable 795,000 859,000
Accrued expenses 7,685,000 3,368,000
Accrued employee benefits 747,000 1,144,000
Deferred research and development tax credit-current portion 1,101,000 1,614,000
Loans payable-current 57,000 61,000
Operating lease liability-current portion 618,000 539,000
Total Current Liabilities 11,003,000 7,585,000
Non-current Liabilities    
Non-current contingent consideration 10,793,000 6,973,000
Loan Payable - non-current 1,654,000 92,000
Non-current deferred research and development tax credit 215,000 762,000
Non-current operating lease liability 433,000 873,000
Total Liabilities 24,098,000 16,285,000
Commitments and Contingencies (Note 13)
Stockholders' Equity:    
Preferred Stock; 10,000,000 authorized; none issued or outstanding at September 30, 2025 and December 31, 2024
Common stock, $0.001 par value; 350,000,000 shares authorized, 10,333,572 issued and 10,304,762 outstanding at September 30, 2025 and 2,811,259 issued and 2,782,449 outstanding at December 31, 2024 9,000 3,000
Additional paid-in capital 362,968,000 355,501,000
Treasury stock at cost, 28,809 shares at September 30, 2025 and at December 31, 2024 (288,000) (288,000)
Accumulated other comprehensive income (loss) 763,000 (1,178,000)
Accumulated deficit (356,714,000) (334,971,000)
Total Stockholders' Equity 6,738,000 19,067,000
Total Liabilities and Stockholders' Equity $ 30,836,000 $ 35,352,000